Linac primary barrier transmission: Flattening filter free and field size dependence.


Journal

Journal of applied clinical medical physics
ISSN: 1526-9914
Titre abrégé: J Appl Clin Med Phys
Pays: United States
ID NLM: 101089176

Informations de publication

Date de publication:
Mar 2023
Historique:
revised: 08 11 2022
received: 18 07 2022
accepted: 15 12 2022
pubmed: 6 1 2023
medline: 21 3 2023
entrez: 5 1 2023
Statut: ppublish

Résumé

There is widespread consensus in the literature that flattening filter free (FFF) beams have a lower primary barrier transmission than flattened beams. Measurements presented here, however, show that for energy compensated FFF beams, the barrier transmission can be as much as 70% higher than for flattened beams. The ratio of the FFF barrier transmission to the flattened beam barrier transmission increases with increasing barrier thickness. The use of published FFF TVL data for energy compensated FFF beams could lead to an order of magnitude underestimate of the air kerma rate. There are little data in the literature on the field size dependence of the barrier transmission for flattened beams. Barrier transmission depends on the field size at the barrier, not at isocenter Measurements are presented showing the relative dependence of barrier transmission on the field size, measured at the barrier, for 6 MV and 10 MV beams. An analytical fitting formula is provided for the field size dependence. For field sizes greater than about 150 cm in side length, the field size dependence is minimal. For field sizes less than about 100 cm, the transmission declines rapidly as the field size decreases.

Identifiants

pubmed: 36601672
doi: 10.1002/acm2.13886
pmc: PMC10018660
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e13886

Informations de copyright

© 2022 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, LLC on behalf of The American Association of Physicists in Medicine.

Références

Z Med Phys. 2014 Mar;24(1):38-48
pubmed: 23763984
J Appl Clin Med Phys. 2022 Apr;23(4):e13574
pubmed: 35235233
J Appl Clin Med Phys. 2023 Mar;24(3):e13886
pubmed: 36601672
Med Phys. 2006 Sep;33(9):3578
pubmed: 28525064
J Appl Clin Med Phys. 2015 May 08;16(3):5219
pubmed: 26103482
Health Phys. 1984 Dec;47(6):811-8
pubmed: 6548989
Med Phys. 2014 May;41(5):052103
pubmed: 24784392
Phys Med Biol. 2009 Mar 7;54(5):1265-73
pubmed: 19190359
Med Phys. 2002 Mar;29(3):391-402
pubmed: 11930914
Phys Med Biol. 2016 Dec 7;61(23):8360-8394
pubmed: 27819253

Auteurs

Patrick N McDermott (PN)

Beaumont Health System (now Corewell Health), Royal Oak, Michigan, USA.

Douglas Drake (D)

Beaumont Health System, Royal Oak, Michigan, USA.

Cory Knill (C)

Beaumont Health System, Dearborn, Michigan, USA.

Michael D Sigler (MD)

Beaumont Health System, Lenox, Michigan, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH